What is Nuvation Bio's change in accrued liabilities?

Nuvation Bio (NUVB) reported change in accrued liabilities of -$12.32M in Q1 2026.

How has Nuvation Bio's change in accrued liabilities changed year-over-year?

Nuvation Bio's change in accrued liabilities decreased by 37.8% year-over-year, from -$8.94M to -$12.32M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Nuvation Bio NUVB Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Nuvalent, Inc.NUVL

-$2.13M-472%

ArriVent BioPharma, Inc.AVBP

-$3.83M+21.5%

Syndax PharmaceuticalsSNDX

-$28.35M-1,019%

IDEAYA Biosciences, Inc.IDYA

$2.73M-5.1%

ImmunityBio, Inc.IBRX

$3.14M+124%

Summit TherapeuticsSMMT

$12.22M+658%

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's change in accrued liabilities?: Nuvation Bio (NUVB) reported change in accrued liabilities of -$12.32M in Q1 2026.
How has Nuvation Bio's change in accrued liabilities changed year-over-year?: Nuvation Bio's change in accrued liabilities decreased by 37.8% year-over-year, from -$8.94M to -$12.32M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.